Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
EE Benarroch - Mayo Clinic Proceedings, 2012 - Elsevier
Postural tachycardia syndrome (POTS) is defined by a heart rate increment of 30 beats/min
or more within 10 minutes of standing or head-up tilt in the absence of orthostatic …
or more within 10 minutes of standing or head-up tilt in the absence of orthostatic …
“When,”“where,” and “how” of SARS-CoV-2 infection affects the human cardiovascular system: a narrative review
Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory
coronavirus-2 (SARS-CoV-2). Several explanations for the development of cardiovascular …
coronavirus-2 (SARS-CoV-2). Several explanations for the development of cardiovascular …
Apparatus and methods for prevention of syncope
(57) ABSTRACT A monitoring system has biomechanical sensors, physiologi cal sensors
and a controller which receive sensory inputs from the sensors to provide output signals for …
and a controller which receive sensory inputs from the sensors to provide output signals for …
Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways
Postural orthostatic tachycardia syndrome (POTS) is a cardiovascular autonomic disorder
characterized by excessive heart rate increase on standing, leading to debilitating symptoms …
characterized by excessive heart rate increase on standing, leading to debilitating symptoms …
Physical health and mental fatigue disability associated with long COVID: baseline results from a US nationwide cohort
Background Persistent symptoms after severe acute respiratory disease coronavirus 2
(SARS-COV-2; long COVID) occur in 10%-55% of individuals, but the impact on daily …
(SARS-COV-2; long COVID) occur in 10%-55% of individuals, but the impact on daily …
Single centre experience of ivabradine in postural orthostatic tachycardia syndrome
C McDonald, J Frith, JL Newton - Europace, 2011 - academic.oup.com
Aims Postural orthostatic tachycardia syndrome (POTS) is associated with tachycardia on
orthostasis. Patients frequently report palpitations, presyncope, and fatigue. Conventional …
orthostasis. Patients frequently report palpitations, presyncope, and fatigue. Conventional …
Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an A ustralian cohort
GK Reynolds, DP Lewis… - Journal of internal …, 2014 - Wiley Online Library
Objective Patients with chronic fatigue syndrome (CFS) are frequently diagnosed with
comorbid postural orthostatic tachycardia syndrome (POTS), suggesting a shared …
comorbid postural orthostatic tachycardia syndrome (POTS), suggesting a shared …
Autonomic dysfunction in multiple sclerosis
I Adamec, M Habek - Clinical Neurology and Neurosurgery, 2013 - Elsevier
Multiple sclerosis (MS) is the leading cause of neurological disability in young adults. Since
the pathophysiology of MS is characterized by dissemination in space, as well as in time, the …
the pathophysiology of MS is characterized by dissemination in space, as well as in time, the …
Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome
F Zhang, X Li, T Ochs, L Chen, Y Liao, C Tang… - Journal of the American …, 2012 - jacc.org
Objectives: This study was designed to explore the predictive value of the midregional
fragment of pro-adrenomedullin (MR-proADM) in assessing the therapeutic efficacy of …
fragment of pro-adrenomedullin (MR-proADM) in assessing the therapeutic efficacy of …
Ivabradine for the treatment of postural orthostatic tachycardia syndrome: a systematic review
ME Gee, AK Watkins, JN Brown, EJA Young - American Journal of …, 2018 - Springer
Introduction Postural orthostatic tachycardia syndrome (POTS) impacts millions of patients,
but there is currently no gold standard treatment for this condition. Ivabradine is a novel …
but there is currently no gold standard treatment for this condition. Ivabradine is a novel …